PARA vs. PFE
Compare and contrast key facts about Paramount Global Class B (PARA) and Pfizer Inc. (PFE).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: PARA or PFE.
Key characteristics
| PARA | PFE | |
|---|---|---|
| YTD Return | -28.49% | 4.74% |
| 1Y Return | -0.84% | 1.50% |
| 3Y Return (Ann) | -32.24% | -9.16% |
| 5Y Return (Ann) | -19.53% | -0.51% |
| 10Y Return (Ann) | -13.45% | 4.14% |
| Sharpe Ratio | -0.05 | -0.08 |
| Sortino Ratio | 0.39 | 0.06 |
| Omega Ratio | 1.05 | 1.01 |
| Calmar Ratio | -0.03 | -0.04 |
| Martin Ratio | -0.09 | -0.23 |
| Ulcer Index | 28.70% | 8.17% |
| Daily Std Dev | 58.54% | 24.20% |
| Max Drawdown | -93.29% | -69.25% |
| Current Drawdown | -88.57% | -46.86% |
Fundamentals
| PARA | PFE | |
|---|---|---|
| Market Cap | $7.34B | $163.54B |
| EPS | -$8.74 | -$0.47 |
| PEG Ratio | 0.29 | 0.22 |
| Total Revenue (TTM) | $22.14B | $42.41B |
| Gross Profit (TTM) | $6.26B | $24.40B |
| EBITDA (TTM) | $1.27B | $9.98B |
Correlation
The correlation between PARA and PFE is 0.25, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
PARA vs. PFE - Performance Comparison
In the year-to-date period, PARA achieves a -28.49% return, which is significantly lower than PFE's 4.74% return. Over the past 10 years, PARA has underperformed PFE with an annualized return of -13.45%, while PFE has yielded a comparatively higher 4.14% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
PARA vs. PFE - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Paramount Global Class B (PARA) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
PARA vs. PFE - Dividend Comparison
PARA's dividend yield for the trailing twelve months is around 1.92%, less than PFE's 5.79% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PARA Paramount Global Class B | 1.92% | 2.64% | 5.69% | 3.18% | 2.58% | 1.86% | 1.65% | 1.22% | 1.04% | 1.27% | 0.98% | 0.75% |
PFE Pfizer Inc. | 5.79% | 5.70% | 3.12% | 2.64% | 3.91% | 3.68% | 3.12% | 3.53% | 3.69% | 3.47% | 3.34% | 3.13% |
Drawdowns
PARA vs. PFE - Drawdown Comparison
The maximum PARA drawdown since its inception was -93.29%, which is greater than PFE's maximum drawdown of -69.25%. Use the drawdown chart below to compare losses from any high point for PARA and PFE. For additional features, visit the drawdowns tool.
Volatility
PARA vs. PFE - Volatility Comparison
The current volatility for Paramount Global Class B (PARA) is 4.62%, while Pfizer Inc. (PFE) has a volatility of 6.13%. This indicates that PARA experiences smaller price fluctuations and is considered to be less risky than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
PARA vs. PFE - Financials Comparison
This section allows you to compare key financial metrics between Paramount Global Class B and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities